Contact
Please use this form to send email to PR contact of this press release:
John H. Johnson Agrees to Become Permanent Chief Executive Officer of Melinta Therapeutics
TO:
Please use this form to send email to PR contact of this press release:
John H. Johnson Agrees to Become Permanent Chief Executive Officer of Melinta Therapeutics
TO: